Systematic optimization of active protein expression using GFP as a folding reporter

被引:20
作者
Omoya, K [1 ]
Kato, Z [1 ]
Matsukuma, E [1 ]
Li, AL [1 ]
Hashimoto, K [1 ]
Yamamoto, Y [1 ]
Ohnishi, H [1 ]
Kondo, N [1 ]
机构
[1] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan
关键词
D O I
10.1016/j.pep.2004.04.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Many recombinant proteins have been used as drugs; however, human proteins expressed using heterologous hosts are often insoluble. To obtain correctly folded active proteins, many optimizations of expression have been attempted but usually are found to be applicable only for specific targets. Interleukin-18 (IL-18) has a key role in many severe disorders including autoimmune diseases, and therapeutic approaches using IL-18 have been reported. However, production of IL-18 in Escherichia coli resulted in extensive inclusion body formation and previous conventional screenings of expression conditions could obtain only a condition with a low yield. To address the problem, we applied a folding reporter system using green fluorescent protein (GFP) for screening of the expression conditions for hIL-18. The established system efficiently screened many conditions, and optimized conditions for the expression of hIL-18 significantly enhanced the final yield of the active protein. Systematic screening using a GFP reporter system could be applied for the production of other proteins and in other organisms. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 19 条
[1]   Structural proteomics: prospects for high throughput sample preparation [J].
Christendat, D ;
Yee, A ;
Dharamsi, A ;
Kluger, Y ;
Gerstein, M ;
Arrowsmith, CH ;
Edwards, AM .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2000, 73 (05) :339-345
[2]   Preclinical safety of recombinant human interleukin-18 [J].
Herzyk, DJ ;
Bugelski, PJ ;
Hart, TK ;
Wier, PJ .
TOXICOLOGIC PATHOLOGY, 2003, 31 (05) :554-561
[3]   Preparation of active recombinant cathepsin K expressed in bacteria as inclusion body [J].
Hwang, HS ;
Chung, HS .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (03) :541-546
[4]   The structure and binding mode of interleukin-18 [J].
Kato, Z ;
Jee, J ;
Shikano, H ;
Mishima, M ;
Ohki, I ;
Ohnishi, H ;
Li, AL ;
Hashimoto, K ;
Matsukuma, E ;
Omoya, K ;
Yamamoto, Y ;
Yoneda, T ;
Hara, T ;
Kondo, N ;
Shirakawa, M .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (11) :966-971
[5]   Measurement of interferon-γ by high-throughput fluorometric microvolume assay technology system [J].
Komatsu, N ;
Shichijo, S ;
Maeda, Y ;
Itoh, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 263 (1-2) :169-176
[6]   Optimized gene synthesis and high expression of human interleukin-18 [J].
Li, AL ;
Kato, Z ;
Ohnishi, H ;
Hashimoto, K ;
Matsukuma, E ;
Omoya, K ;
Yamamoto, Y ;
Kondo, N .
PROTEIN EXPRESSION AND PURIFICATION, 2003, 32 (01) :110-118
[7]   Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18 [J].
Liu, BL ;
Novick, D ;
Kim, SH ;
Rubinstein, M .
CYTOKINE, 2000, 12 (10) :1519-1525
[8]   Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18 [J].
Nagai, H ;
Hara, I ;
Horikawa, T ;
Fujii, M ;
Kurimoto, M ;
Kamidono, S ;
Ichihashi, M .
CANCER INVESTIGATION, 2000, 18 (03) :206-213
[9]   Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu [J].
Nakanishi, K ;
Yoshimoto, T ;
Tsutsui, H ;
Okamura, H .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (01) :53-72
[10]   A system using convertible vectors for screening soluble recombinant proteins produced in Escherichia coli from randomly fragmented cDNAs [J].
Nakayama, M ;
Ohara, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (03) :825-830